(Q34430651)

2 August 2017

1 reference

title

Neuropathic pain in Anderson-Fabry disease: pathology and therapeutic options (English)

1 reference

2 August 2017

0 references

0 references

1 reference

MacDermot J

1

1 reference

2 August 2017

MacDermot KD

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

European Journal of Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

429

1 reference

2 August 2017

issue

1-3

1 reference

2 August 2017

page(s)

121-125

1 reference

Clinical features of and recent advances in therapy for Fabry disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

A prospective double-blind study of plasma exchange therapy for the acroparesthesia of Fabry's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Fabry disease: Significance of ultrastructural localization of lipid inclusions in dermal nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Fabry disease: impaired autonomic function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Fabry disease: immunocytochemical characterization of neuronal involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Pathological study of the sural nerve in Fabry's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Involvement of dorsal root ganglia in Fabry's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Successful treatment of painful crises of Fabry disease with low dose morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Functional and structural basis of thermoreception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Relief of chronic burning pain in Fabry disease with neurotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Survey of pain management therapy provided for children with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

Relative hypoxia of the extremities in Fabry disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901312-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01312-7

1 reference

2 August 2017

1 reference